Thill M - Search Results

1

Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery.

Pfob A, Sidey-Gibbons C, Rauch G, Thomas B, Schaefgen B, Kuemmel S, Reimer T, Hahn M, Thill M, Blohmer JU, Hackmann J, Malter W, Bekes I, Friedrichs K, Wojcinski S, Joos S, Paepke S, Degenhardt T, Rom J, Rody A, van Mackelenbergh M, Banys-Paluchowski M, Große R, Reinisch M, Karsten M, Golatta M, Heil J. Pfob A, et al. Among authors: thill m. J Clin Oncol. 2022 Jun 10;40(17):1903-1915. doi: 10.1200/JCO.21.02439. Epub 2022 Feb 2. J Clin Oncol. 2022. PMID: 35108029 Clinical Trial.

2

MarginProbe®--final results of the German post-market study in breast conserving surgery of ductal carcinoma in situ.

Thill M, Dittmer C, Baumann K, Friedrichs K, Blohmer JU. Thill M, et al. Breast. 2014 Feb;23(1):94-6. doi: 10.1016/j.breast.2013.11.002. Epub 2013 Dec 2. Breast. 2014. PMID: 24291375

3

Intraoperative assessment of margins in breast conservative surgery--still in use?

Thill M, Baumann K, Barinoff J. Thill M, et al. J Surg Oncol. 2014 Jul;110(1):15-20. doi: 10.1002/jso.23634. Epub 2014 May 24. J Surg Oncol. 2014. PMID: 24863286 Review.

4

Combined treatment of breast cancer cell lines with vitamin D and COX-2 inhibitors.

Thill M, Reichert K, Woeste A, Polack S, Fischer D, Hoellen F, Rody A, Friedrich M, Köster F. Thill M, et al. Anticancer Res. 2015 Feb;35(2):1189-95. Anticancer Res. 2015. PMID: 25667510

5

Vitamin D inhibits ovarian cancer cell line proliferation in combination with celecoxib and suppresses cyclooxygenase-2 expression.

Thill M, Woeste A, Reichert K, Fischer D, Rody A, Friedrich M, Köster F. Thill M, et al. Anticancer Res. 2015 Feb;35(2):1197-203. Anticancer Res. 2015. PMID: 25667511

6

Lack of difference in acute nephrotoxicity of intravenous bisphosphonates zoledronic acid and ibandronate in women with breast cancer and bone metastases.

Luedders DW, Steinhoff J, Thill M, Rody A, Bohlmann MK. Luedders DW, et al. Among authors: thill m. Anticancer Res. 2015 Mar;35(3):1797-802. Anticancer Res. 2015. PMID: 25750345 Clinical Trial.

7

Targeted Therapy in HER2-Positive Breast Cancer.

Thill M, Kraft C, Friedrich M. Thill M, et al. Oncol Res Treat. 2016;39(5):295-302. doi: 10.1159/000446038. Epub 2016 Apr 26. Oncol Res Treat. 2016. PMID: 27173915

8

Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasion.

Hoellen F, Waldmann A, Banz-Jansen C, Rody A, Heide M, Köster F, Ribbat-Idel J, Thorns C, Gebhard M, Oberländer M, Habermann JK, Thill M. Hoellen F, et al. Among authors: thill m. Oncol Lett. 2016 Oct;12(4):2351-2356. doi: 10.3892/ol.2016.4925. Epub 2016 Jul 29. Oncol Lett. 2016. PMID: 27698799 Free PMC article.

9

Claudin-1 expression in cervical cancer.

Hoellen F, Waldmann A, Banz-Jansen C, Holtrich U, Karn T, Oberländer M, Habermann JK, Hörmann M, Köster F, Ribbat-Idel J, Thill M, Rody A, El-Balat A, Hanker L. Hoellen F, et al. Among authors: thill m. Mol Clin Oncol. 2017 Nov;7(5):880-884. doi: 10.3892/mco.2017.1391. Epub 2017 Aug 25. Mol Clin Oncol. 2017. PMID: 29181184 Free PMC article.

10

Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell Lines.

Friedrich M, Reichert K, Woeste A, Polack S, Fischer D, Hoellen F, Rody A, Köster F, Thill M. Friedrich M, et al. Among authors: thill m. Anticancer Res. 2018 Feb;38(2):1201-1207. doi: 10.21873/anticanres.12340. Anticancer Res. 2018. PMID: 29374758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters